Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein

Protein and Peptide Letters

Volumn 16, Issue 3, 2009, Pages 217-229

  Sakudo, Akikazu ^a   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Loss of function; Mitochondria; Neurodegenerative disease; Oxidative stress; Prion protein; PrP deficient cells

Indexed keywords

DIAGNOSTIC AGENT; PRION PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PRION DISEASE;

ALZHEIMER DISEASE; ANIMALS; HUMANS; PRION DISEASES; PRPC PROTEINS; PRPSC PROTEINS;

MUS;

EID: 63449136424     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609787601732     Document Type: Article

References (140)

1. Prusiner, S.B, Prions. Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 13363-13383.
2. Anderson, R.M.; Donnelly, CA.; Ferguson, N.M.; Woolhouse, M.E.; Watt, C.J.; Udy, HJ.; MaWhinney, S.; Dunstan, S.P.; Southwood, T.R.; Wilesmith, J.W.; Ryan, J.B.; Hoinville, L.J.; Hillerton, J.E.; Austin, A.R.; Wells, G.A. Transmission dynamics and epidemiology of BSE in British cattle. Nature, 1996, 382, 779-788.
3. http://www.oie.int/eng/info/en-esbmonde.htm; 2008 [accessed June 2008].
4. Hill, A.F.; Desbruslais, M.; Joiner, S.; Sidle, K.C.; Gowland, I.; Collinge, J.; Doey, L.J.; Lantos, P. The same prion strain causes vCJD and BSE. Nature, 1997, 389, 448-450.
5. Bruce, M.E.; Will, R.G.; Ironside, J.W.; McConnell, I.; Drummond, D.; Suttie, A.; McCardle, L.; Chree, A.; Hope, J.; Birkett, C; Cousens, S.; Fraser, H.; Bostock, C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature, 1997, 389, 498-501.
6. http://www.who.int/zoonoses/diseases/prion-diseases/en/; 2008 [accessed June 2008].
7. Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science, 1982, 216, 136-144.
8. Oesch, B.; Westaway, D.; Walchli, M.; McKinley, M.P.: Kent, S.B.; Aebersold, R.; Barry, R.A.; Tempst, P.; Teplow, D.B.; Hood, L.E.; Prusiner, S.B.; Weissmann C. A cellular gene encodes scrapie PrP 27-30 protein. Cell, 1985, 40, 735-746.
9. Basier, K.; Oesch, B.; Scott, M.; Westaway, D.; Walchli, M.; Groth, D.F.; McKinley, M.P.; Prusiner, S.B.; Weissmann, C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell, 1986, 46, 417-428.
10. Collinge, J.; Clarke, A.R. A general model of prion strains and their pathogenicity. Science, 2007, 318, 930-936.
11. Brown P. In Immunologic Mechanisms in Neurologic and Psychiatric Disease; Waksman, B. H., Ed.; Raven Press Ltd.: New York, 1990: pp. 305-313.
12. Bueler, H.; Fischer, M.: Lang, Y.; Bluethmann, H.; Lipp, H.P.; DeArmond, S.J.; Prusiner, S.B.; Aguet, M.; Weissmann, C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 1992, 356, 577-582.
13. Chesebro, B.; Trifilo, M.; Race, R.; Meade-White, K.; Teng, C; LaCasse, R.; Raymond, L.; Favara, C; Baron, G.; Priola, S.; Caughey, B.; Masliah, E.; Oldstone, M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science, 2005, 308, 1435-1439.
14. Yokoyama, T.; Kimura, K.M.; Ushiki, Y.; Yamada, S.; Morooka, A.; Nakashiba, T.; Sassa, T.; Itohara, S. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem., 2001, 276, 11265-11271.
15. Brown, D.R. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence. Folia. Neuropathol., 2005, 43, 229-243.
16. Milhavet, O.; Lehmann, S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res. Brain Res. Rev., 2002, 38, 328-339.
17. Rossi, L.; Lombardo, M.F.; Ciriolo, M.R.; Rotilio, G. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem. Res., 2004, 29, 493-504.
18. Crozet, C; Beranger, F.; Lehmann, S. Cellular pathogenesis in prion diseases. Vet. Res., 2008, 39, 44.
19. Miele, G.; Jeffrey, M.; Tumbull, D.; Manson, J.; Clinton, M. Ablation of cellular prion protein expression affects mitochondrial numbers and morphology. Biochem. Biophys. Res. Commun., 2002, 291, 372-377.
20. Paterson, A.W.; Curtis, J.C.; Macleod, N.K. Complex I specific increase in superoxide formation and respiration rate by PrP-null mouse brain mitochondria. J. Neurochem., 2008, 105, 177-191.
21. Sakudo, A.; Onodera, T.; Suganuma, Y.; Kobayashi, T.; Saeki, K.; Ikuta, K. Recent advances in clarifying prion protein functions using knockout mice and derived cell lines. Mini Rev. Med. Chem., 2006, 6, 589-601.
22. Sakudo, A.; Nakamura, I.; Ikuta, K.; Onodera, T. Recent developments in prion disease research: diagnostic tools and in vitro cell culture models. J. Vet. Med. Sci., 2007, 69, 329-337.
23. Wadsworth, J.D.; Hill, A.F.; Beck, J.A.; Collinge, J. Molecular and clinical classification of human prion disease. Br. Med. Bull., 2003, 66, 241-254.
24. Bosque, P.J.; Prusiner, S.B. Cultured cell sublines highly susceptible to prion infection. J. Virol., 2000, 74, 4377-4386.
25. Enari, M.; Flechsig, E.; Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA, 2001, 98, 9295-9299.
26. Winklhofer, K.F.; Hartl, F.U.; Tatzeit, J. A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds. FEBS Lett., 2001, 503, 41-45.
27. Rhie, A.; Kirby, L.; Sayer, N.; Wellesley, R.; Disterer, P.; Sylvester, I.; Gill, A.; Hope, J.; James, W.; Tahiri-Alaoui, A. Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J. Biol. Chem., 2003, 278, 39697-39705.
28. Sayer, N.M.; Cubin, M.; Rhie, A.; Bullock, M.; Tahiri-Alaoui, A.; James, W. Structural determinants of conformationally selective, prion-binding aptamers. J. Biol. Chem., 2004, 279, 13102-13109.
29. Weiss, S.; Proske, D.; Neumann, M.; Groschup, M.H.; Kretzschmar, H.A.; Famulok, M.; Winnacker, E.L. RNA aptamers specifically interact with the prion protein PrP. J. Virol., 1997, 71, 8790-8797.
30. Gregori, L.; Gray, B.N.; Rose, E.; Spinner, D.S.; Kascsak, R.J.; Rohwer, R.G. A sensitive and quantitative assay for normal PrP in plasma. J. Virol. Methods, 2008, 149, 251-259.
31. Wadsworth, J.D.; Joiner, S.; Hill, A.F.; Campbell, T.A.; Desbruslais, M.; Luthert, P.J.; Collinge, J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet, 2001, 358, 171-180.
32. Iwata, N.; Sato, Y.; Higuchi, Y.; Nohtomi, K.; Nagata, N.; Hasegawa, H.; Tobiume, M.; Nakamura, Y.; Hagiwara, K.; Furuoka, H.; Horiuchi, M.; Yamakawa, Y.; Sata, T. Distribution of PrP(Sc) in cattle with bovine spongiform encephalopathy slaughtered at abattoirs in Japan. Jpn. J. Infect. Dis., 2006, 59, 100-107.
33. Orge, L.; Galo, A.; Machado, C; Lima, C; Ochoa, C.; Silva, J.; Ramos, M.; Simas, J.P. Identification of putative atypical scrapie in sheep in Portugal. J. Gen. Virol., 2004, 85, 3487-3491.
34. Taraboulos, A.; Jendroska, K.; Serban, D.; Yang, S.L.; DeArmond, S.J.; Prusiner, S.B. Regional mapping of prion proteins in brain. Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 7620-7624.
35. Ritchie, D.L.: Head, M.W.; Ironside, J.W. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol. Appl. Neurobiol, 2004, 30, 360-368.
36. Schulz-Schaeffer, W.J.; Tschoke, S.; Kranefuss, N.; Drose, W.; Hause-Reitner, D.; Giese, A.; Groschup, M.H.; Kretzschmar, H.A. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am. J. Pathol., 2000, 156, 51-56.
37. Safar, J.: Wille, H.: Itri, V.; Groth, D.; Serban, H.: Torchia, M.; Cohen, F.E.; Prusiner, S.B. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med., 1998, 4, 1157-1165.
38. Murayama, Y.; Yoshioka, M.; Horii, H.; Takata, M.; Miura, K.; Shinagawa, M. Specific detection of prion antigenic determinants retained in bovine meat and bone meal by flow microbead immunoassay. J. Appl. Microbiol, 2006, 101, 369-376.
39. Jackman, R.; Schmerr, M.J. Analysis of the performance of antibody capture methods using fluorescent peptides with capillary zone electrophoresis with laser-induced fluorescence. Electrophoresis, 2003, 24, 892-896.
40. Schmerr, M.J.; Jenny, A.L.; Bulgin, M.S.; Miller, J.M.; Hamir, A.N.; Cutlip, R.C.; Goodwin, K.R. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J. Chromatogr. A, 1999, 853, 207-214.
41. Bieschke, J.; Giese, A.; Schulz-Schaeffer, W.; Zerr, I.; Poser, S.; Eigen, M.; Kretzschmar, H. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl. Acad. Sci. USA, 2000, 97, 5468-5473.
42. Giese, A.; Bieschke, J.; Eigen, M.; Kretzschmar, H.A. Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases. Arch. Virol. Suppl., 2000, 145, 161-171.
43. Schmitt, J.; Beekes, M.; Brauer, A.; Udelhoven, T.; Lasch, P.; Naumann, D. Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy. Anal. Chem., 2002, 74, 3865-3868.
44. Rubenstein, R.; Gray, P.C.; Wehlburg, C.M.; Wagner, J.S.; Tisone, G.C. Detection and discrimination of PrPSc by multi-spectral ultraviolet fluorescence. Biochem. Biophys. Res. Commun., 1998, 246, 100-106.
45. Saborio, O.P.; Permanne, B.; Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature, 2001, 411, 810-813.
46. Castilla, J.; Saa, P.; Hetz, C.; Soto, C. In vitro generation of infectious scrapie prions. Cell, 2005, 121, 195-206.
47. Saa, P.; Castilla, J.; Soto, C. Presymptomatic detection of prions in blood. Science, 2006, 313, 92-94.
48. Castilla, J.; Saa, P.; Soto, C. Detection of prions in blood. Nat. Med., 2005, 11, 982-985.
49. Soto, C.; Anderes, L.; Suardi, S.; Cardone, F.; Castilla, J.; Frossard, M.J.; Peano, S.; Saa, P.; Limido, L.; Carbonatto, M.; Ironside, J.; Torres, J.M.; Pocchiari, M.; Tagliavini, F. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett., 2005, 579, 638-642.
50. Castilla, J.; Saa, P.; Morales, R.; Abid, K.; Maundrell, K.; Soto, C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol, 2006, 412, 3-21.
51. Jones, M.; Peden, A.H.; Prowse, C.V.; Groner, A.; Manson, J.C.; Turner, M.L.; Ironside, J.W.; MacGregor, I.R.; Head, M.W. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J. Pathol., 2007, 213, 21-26.
52. Kurt, T.D.; Perrott, M.R.; Wilusz, C.J.; Wilusz, L; Supattapone, S.; Telling, G.C.; Zabel, M.D.; Hoover, E.A. Efficient in vitro amplification of chronic wasting disease PrPRES. J. Virol., 2007, 81, 9605-9608.
53. Murayama, Y.; Yoshioka, M.; Yokoyama, T.; Iwamaru, Y.; Imamura, M.; Masujin, K.; Yoshiba, S.; Mohri, S. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci. Lett., 2007, 413, 270-273.
54. Atarashi, R.; Moore, R.A.; Sim, V.L.; Hughson, A.G.; Dorward, D.W.; Onwubiko, H.A.; Priola, S.A.; Caughey, B. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods, 2007, 4, 645-650.
55. Atarashi, R.; Wilham, J.M.; Christensen, L.; Hughson, A.G.; Moore, R.A.; Johnson, L.M.; Onwubiko, H.A.; Priola, S.A.; Caughey, B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods, 2008, 5, 211-212.
56. Atarashi, R. Recent advances in cell-free PrPSc amplification technique. Protein Pept. Lett. 2009, in press.
57. Aguzzi, A.; Polymenidou, M. Mammalian prion biology: one century of evolving concepts. Cell, 2004, 116, 313-327.
58. Tobler, L; Gaus, S.E.; Deboer, T.; Achermann, P.; Fischer, M.; Rulicke, T.; Moser, M.; Oesch, B.; McBride, P.A.; Manson, J.C. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature, 1996, 380, 639-642.
59. Collinge, L; Whittington, M.A.; Sidle, K.C.; Smith, C.J.; Palmer, M.S.; Clarke, A.R.; Jefferys, J.G. Prion protein is necessary for normal synaptic function. Nature, 1994, 370, 295-297.
60. Valenti, P.; Cozzio, A.; Nishida, N.; Wolfer, D.P.; Sakaguchi, S.; Lipp, H.P. Similar target, different effects: late-onset ataxia and spatial learning in prion protein-deficient mouse lines. Neurogenetics, 2001, 3, 173-184.
61. Sakudo, A.; Onodera, T.; Ikuta, K. Prion protein gene-deficient cell lines: powerful tools for prion biology. Microbiol. Immunol, 2007, 51, 1-13.
62. Forloni, G.; Angeretti, N.; Chiesa, R.; Monzani, E.; Salmona, M.; Bugiani, O.; Tagliavini, F. Neurotoxicity of a prion protein fragment. Nature, 1993, 362, 543-546.
63. Pillot, T.; Drouet, B.; Pincon-Raymond, M.; Vandekerckhove, J.; Rosseneu, M.; Chambaz, J. A nonfibrillar form of the fusogenic prion protein fragment [118-135] induces apoptotic cell death in rat cortical neurons. J. Neurochem., 2000, 75, 2298-2308.
64. Vassallo, N. Properties and pathogenicity of prion-derived peptides. Protein Pept. Lett., 2009, in press.
65. Bendheim, P.E.; Brown, H.R.; Rudelli, R.D.; Scala, L.J.; Goller, N.L.; Wen, G.Y.; Kascsak, R.J.; Cashman, N.R.; Bolton, D.C. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology, 1992, 42, 149-156.
66. Moudjou, M.; Frobert, Y.; Grassi, J.; La Bonnardiere, C. Cellular prion protein status in sheep: tissue-specific biochemical signatures. J. Gen. Virol., 2001, 82, 2017-2024.
67. Brown, D.R.; Qin, K.; Herms, J.W.; Madlung, A.; Manson, J.; Strome, R.; Fraser, P.E.; Kruck, T.; von Bohlen, A.; Schulz-Schaeffer, W.; Giese, A.; Westaway, D.; Kretzschmar, H. The cellular prion protein binds copper in vivo. Nature, 1997, 390, 684-687.
68. Viles, J.H.; Cohen, F.E.; Prusiner, S.B.; Goodin, D.B.; Wright, P.E.; Dyson, H.J. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 2042-2047.
69. Brown, D.R.; Wong, B.S.: Hafiz, F.; Clive, C; Haswell, S.J.; Jones, I.M. Normal prion protein has an activity like that of superoxide dismutase. Biochem. J., 1999, 344, 1-5.
70. Cui, T.; Daniels, M.; Wong, B.S.; Li, R.; Sy, M.S.; Sassoon, J.; Brown, D.R. Mapping the functional domain of the prion protein. Eur. J. Biochem., 2003, 270, 3368-3376.
71. Jones, S.; Batchelor, M.; Bhelt, D.; Clarke, A.R.; Collinge, J.; Jackson, G.S. Recombinant prion protein does not possess SOD-1 activity. Biochem. J., 2005, 392, 309-312.
72. Sakudo, A.; Nakamura, I.; Tsuji, S.; Ikuta, K. GPI-anchorless human prion protein is secreted and glycosylated but lacks superoxide dismutase activity. Int. J. Mol. Med., 2008, 21, 217-222.
73. Sakudo, A.; Hamaishi, M.; Hosokawa-Kanai, T.; Tuchiya, K.; Nishimura, T.; Saeki, K.; Matsumoto, Y.: Ueda, S.; Onodera, T. Absence of superoxide dismutase activity in a soluble cellular iso-form of prion protein produced by baculovirus expression system. Biochem. Biophys. Res. Commun., 2003, 307, 678-683.
74. Mange, A.; Beranger, F.; Peoc'h, K.; Onodera, T.; Frobert, Y.; Lehmann, S. Alpha- and beta- cleavages of the amino-terminus of the cellular prion protein. Biol. Cell, 2004, 96, 125-132.
75. Hegde, R.S.; Mastrianni, J.A.; Scott, M.R.; DeFea, K.A.; Tremblay, P.; Torchia, M.; DeArmond, S.J.; Prusiner, S.B.; Lingappa, V.R. A transmembrane form of the prion protein in neurodegenerative disease. Science, 1998, 279, 827-834.
76. Zanata, S.M.; Lopes, M.H.; Mercadante, A.F.; Hajj, G.N.: Chiarini, L.B.: Nomizo, R.; Freitas, A.R.: Cabrai, A.L.: Lee, K.S.: Juliano, M.A.; de Oliveira, E.; Jachieri, S.G.; Burlingame, A.; Huang, L.; Linden, R.; Brentani, R.R.; Martins, V.R. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J., 2002, 21, 3307-3316.
77. Brown, D.R.; Schmidt, B.; Kretzschmar, H.A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature, 1996, 380, 345-347.
78. Sakudo, A.; Nakamura, I.; Lee, D.C; Saeki, K.; Ikuta, K.; Onodera, T. Neurotoxic prion protein (PrP) fragment 106-126 requires the N-terminal half of the hydrophobic region of PrP in the PrP-deficient neuronal cell line. Protein Pept. Lett., 2007, 14, 1-6.
79. Forloni, G. Neurotoxicity of beta-amyloid and prion peptides. Curr. Opin. Neurol., 1996, 9, 492-500.
80. Selkoe, D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 2001, 81, 741-766.
81. Haass, C. Take five - BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J., 2004, 23, 483-488.
82. Allinson, T.M.; Parkin, E.T.; Turner, A.J.; Hooper, N.M. ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res., 2003, 74, 342-352.
83. Vincent, B.; Paitel, E.; Saftig, P.; Frobert, Y.; Hartmann, D.; De Strooper, B.; Grassi, J.; Lopez-Perez, E.; Checler, F. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem., 2001, 276, 37743-37746.
84. Cisse, M.A.; Sunyach, C; Lefranc-Jullien, S.; Postina, R.; Vincent, B.; Checler, F. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem., 2005, 280, 40624-40631.
85. Vincent, B.: Cisse, M.A.: Sunyach, C.; Guillot-Sestier, M.V.; Checler, F. Regulation of betaAPP and PrPc cleavage by alphasecretase: mechanistic and therapeutic perspectives. Curr. Alzheimer Res., 2008, 5, 202-211.
86. Parkin, E.T.; Watt, N.T.; Hussain, I.; Eckman, E.A.; Eckman, C.B.; Manson, J.C.; Baybutt, H.N.; Turner, A.J.; Hooper, N.M. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 11062-11067.
87. Hainfellner, J.A.; Wanschitz, J.; Jellinger, K.; Liberski, P.P.; Gullotta, F.; Budka, H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol., 1998, 96, 116-122.
88. Voigtlander, T.; Kloppel, S.; Birner, P.; Jarius, C.; Flicker, H.; Verghese-Nikolakaki, S.; Sklaviadis, T.; Guentchev, M.; Budka, H. Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta Neuropathol., 2001, 101, 417-423.
89. Del Bo, R.; Scarlato, M.; Ghezzi, S.; Martinelli-Boneschi, F.; Fenoglio, C; Galimberti, G.; Galbiati, S.; Virgilio, R.; Galimberti, D.; Ferrarese, C; Scarpini, E.; Bresolin, N.; Comi, G.P. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol. Aging, 2006, 27, 770.
90. Schmitt-Ulms, G.; Hansen, K.; Liu, J.; Cowdrey, C; Yang, J.; DeArmond, S.J.; Cohen, F.E.; Prusiner, S.B.; Baldwin, M.A. Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat. Biotechnol., 2004, 22, 724-731.
91. Taylor, D.R.; Hooper, N.M. Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins. Semin. Cell. Dev. Biol., 2007, 18, 638-648.
92. Butterfield, D.A.; Kanski, J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev., 2001, 122, 945-962.
93. Sakudo, A.; Lee, D.C.; Yoshimura, E.; Nagasaka, S.; Nitta, K.; Saeki, K.; Matsumoto, Y.; Lehmann, S.; Itohara, S.; Sakaguchi, S.; Onodera, T. Prion protein suppresses perturbation of cellular copper homeostasis under oxidative conditions. Biochem. Biophys. Res. Commun., 2004, 313, 850-855.
94. Rossi, L.; De Martino, A.; Marchese, E.; Piccirilli, S.; Rotilio, G.; Ciriolo, M.R. Neurodegeneration in the animal model of Menkes' disease involves Bcl-2-linked apoptosis. Neuroscience, 2001, 103, 181-188.
95. Lombardo, M.F.; Ciriolo, M.R.; Rotilio, G.; Rossi, L. Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells. Cell. Mol. Life Sci., 2003, 60, 1733-1743.
96. Rossi, L.; Arciello, M.; Capo, C.; Rotilio, G. Copper imbalance and oxidative stress in neurodegeneration. Ital. J. Biochem., 2006, 55, 212-221.
97. Matsunaga, A.; Nomura, Y.; Kuroda, S.; Tamura, M.; Nishihira, J.; Yoshimura, N. Energy-dependent redox state of heme a + a3 and copper of cytochrome oxidase in perfused rat brain in situ. Am. J. Physiol., 1998, 275, C1022-1030.
98. Pereira, G.S.; Walz, R.; Bonan, C.D.; Battastini, A.M.; Izquierdo, I.; Martins, V.R.; Brentani, R.R.; Sarkis, J.J. Changes in cortical and hippocampal ectonucleotidase activities in mice lacking cellular prion protein. Neurosci. Lett., 2001, 301, 72-14.
99. Wong, B.S.; Liu, T.; Li, R.; Pan, T.; Petersen, R.B.; Smith, M.A.; Gambetti, P.; Perry, G.; Manson, J.C.; Brown, D.R.; Sy, M.S. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem., 2001, 76, 565-572.
100. Sakudo, A.; Taniuchi, Y.; Kobayashi, T.; Onodera, T.; Ikuta, K. Normal cytochrome C oxidase activity in prion protein genedeficient mice. Protein Pept. Lett., 2008, 15, 250-254.
101. Choi, S.I.; Ju, W.K.; Choi, E.K.; Kim, J.; Lea, H.Z.; Carp, R.I.; Wisniewski, H.M.; Kim, Y.S. Mitochondrial dysfunction induced by oxidative stress in the brains of hamsters infected with the 263 K scrapie agent. Acta Neuropathol., 1998, 96, 279-286.
102. Kuwahara, C; Takeuchi, A.M.; Nishimura, T.; Haraguchi, K.; Kubosaki, A.; Matsumoto, Y.; Saeki, K.; Yokoyama, T.; Itohara, S.; Onodera, T. Prions prevent neuronal cell-line death. Nature, 1999, 400, 225-226.
103. Sakudo, A.; Lee, D.C.; Saeki, K.; Nakamura, Y.; Inoue, K.; Matsumoto, Y.; Itohara, S.; Onodera, T. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun., 2003, 308, 660-667.
104. Nishimura, T.; Sakudo, A.; Hashiyama, Y.; Yachi, A.; Saeki, K.; Matsumoto, Y.; Ogawa, M.; Sakaguchi, S.; Itohara, S.; Onodera, T. Serum withdrawal-induced apoptosis in ZrchI prion protein (PrP) gene-deficient neuronal cell line is suppressed by PrP, independent of Doppel. Microbiol. Immunol., 2007, 51, 457-466.
105. Kim, B.H.; Lee, H.G.; Choi, J.K.; Kim, J.I.; Choi, E.K.; Carp, R.I.; Kim, Y.S. The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res. Mol. Brain Res., 2004, 124, 40-50.
106. Vassallo, N.; Herms, J.; Behrens, C: Krebs, B.; Saeki, K.; Onodera, T.; Windl, O.; Kretzschmar, H.A. Activation of phosphatidy-linositol 3-kinase by cellular prion protein and its role in cell survival. Biochem. Biophys. Res. Commun., 2005, 332, 75-82.
107. Kim, B.H.; Kim, J.I.; Choi, E.K.; Carp, R.I.; Kim, Y.S. A neuronal cell line that does not express either prion or doppel proteins. Neuroreport, 2005, 16, 425-429.
108. Satoh, J.; Yukitake, M.; Kurohara, K.; Nishida, N.; Katamine, S.; Miyamoto, T.; Kuroda, Y. Cultured skin fibroblasts isolated from mice devoid of the prion protein gene express major heat shock proteins in response to heat stress. Exp. Neurol., 1998, 151, 105-115.
109. Satoh, J.; Kuroda, Y.; Katamine, S. Gene expression profile in prion protein-deficient fibroblasts in culture. Am. J. Pathol., 2000, 157, 59-68.
110. Choi, C.J.; Anantharam, V.; Saetveit, N.J.; Houk, R.S.; Kanthasamy, A.; Kanthasamy, A.G. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death. Toxicol. Sci., 2007, 98, 495-509.
111. Schatzl, H.M.; Da Costa, M.; Taylor, L.; Cohen, F.E.; Prusiner, S.B. Prion protein gene variation among primates. J. Mol. Biol., 1995, 245, 362-374.
112. Wopfner, F.; Weidenhofer, G.; Schneider, R.; von Brunn, A.; Gilch, S.; Schwarz, T.F.; Werner, T.; Schatzl, H.M. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions ofthe prion protein. J. Mol. Biol., 1999, 289, 1163-1178.
113. Nishida, N.; Harris, D.A.; Vilette, D.; Laude, H.; Frobert, Y.; Grassi, J.; Casanova, D.; Milhavet, O.; Lehmann, S. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol., 2000, 74, 320-325.
114. Rubenstein, R.; Carp, R.I.; Callahan, S.M. In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells. J. Gen. Virol., 1984, 65, 2191-2198.
115. Gilch, S.; Schmitz, F.; Aguib, Y.; Kehler, C.; Bulow, S.; Bauer, S.; Kremmer, E.; Schatzl, H.M. CpG and LPS can interfere negatively with prion clearance in macrophage and microglial cells. FEBS J., 2007, 274, 5834-5844.
116. Mays, C.E.; Kang, H.E.; Kim, Y.; Shim, S.H.; Bang, J.E.; Woo, H.J.; Cho, Y.H.; Kim, J.B.; Ryou, C. CRBL cells: Establishment, characterization and susceptibility to prion infection. Brain Res., 2008, 1208, 170-180.
117. Vorberg, I.; Raines, A.; Story, B.; Priola, S.A. Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J. Infect. Dis., 2004, 189, 431-439.
118. Ladogana, A.; Liu, Q.: Xi, Y.G.: Pocchiari, M. Proteinase-resistant protein in human neuroblastoma cells infected with brain material from Creutzfeldt-Jakob patient. Lancet, 1995, 345, 594-595.
119. Race, R.E.; Fadness, L.H.: Chesebro, B. Characterization of scrapie infection in mouse neuroblastoma cells. J. Gen. Virol., 1987, 68, 1391-1399.
120. Kikuchi, Y.; Kakeya, T.; Sakai, A.; Takatori, K.; Nakamura, N.; Matsuda, H.; Yamazaki, T.; Tanamoto, K.; Sawada, J. Propagation of a protease-resistant form of prion protein in long-term cultured human glioblastoma cell line T98G. J. Gen. Virol., 2004, 85, 3449-3457.
121. Iwamaru, Y.; Takenouchi, T.; Ogihara, K.; Hoshino, M.; Takata, M.; Imamura, M.; Tagawa, Y.; Hayashi-Kato, H.; Ushiki-Kaku, Y.; Shimizu, Y.; Okada, H,; Shinagawa, M.; Kitani, H,; Yokoyama, T, Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J. Virol., 2007, 81, 1524-1527.
122. Vilette, D.; Andreoletti, O.; Archer, F.; Madelaine, M.F.; Vilotte, J.L.; Lehmann, S.; Laude, H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 4055-4059.
123. Race, R.E.; Caughey, B.; Graham, K.; Ernst, D.; Chesebro, B. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J. Virol., 1988, 62, 2845-2849.
124. Spudich, A.; Frigg, R.; Kilic, E.; Kilic, U.; Oesch, B.; Raeber, A.; Bassetti, C.L.; Hermann, D.M. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol. Dis., 2005, 20, 442-449.
125. Race, R.E.; Priola, S.A.; Bessen, R.A.; Ernst, D.; Dockter, J.; Rall, G.F.; Mucke, L.: Chesebro, B.; Oldstone, M.B. Neuron-specific expression of a hamster prion protein minigene in transgenic mice induces susceptibility to hamster scrapie agent. Neuron, 1995, 15, 1183-1191.
126. Raeber, A.J.: Race, R.E.; Brandner, S.: Priola, S.A.; Sailer, A.; Bessen, R.A.; Mucke, L.; Manson, J.; Aguzzi, A.; Oldstone, M.B.; Weissmann, C; Chesebro, B. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J., 1997, 16, 6057-6065.
127. Scott, M.; Foster, D.; Mirenda, C; Serban, D.; Coufal, F.; Walchli, M.; Torchia, M.; Groth, D.; Carlson, G.; DeArmond, S.J.; West-away, D.; Prusiner, S.B. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell, 1989, 59, 847-857.
128. Telling, G.G.; Haga, T.; Torchia, M.; Tremblay, P.; DeArmond, S.J.; Prusiner, S.B. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev., 1996, 10, 1736-1750.
129. Sakudo, A.; Wu, G.; Onodera, T.; Ikuta, K. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun., 2008, 365, 164-169.
130. Shmerling, D.; Hegyi, I.; Fischer, M.; Blattler, T.; Brandner, S.; Gotz, J.; Rulicke, T.; Flechsig, E.; Cozzio, A.; von Mering, C.; Hangartner, C; Aguzzi, A.; Weissmann, C. Expression of aminoterminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell, 1998, 93, 203-214.
131. Supattapone, S.; Muramoto, T.; Legname, G.; Mehlhorn, I.; Cohen, F.E.; DeArmond, S.J.; Prusiner, S.B.; Scott, M.R. Identification of two prion protein regions that modify scrapie incubation time. J. Virol., 2001, 75, 1408-1413.
132. Supattapone, S.; Bosque, P.; Muramoto, T.; Wille, H.; Aagaard, C; Peretz, D.; Nguyen, H.O.; Heinrich, C; Torchia, M.; Safar, J.; Cohen, F.E.; DeArmond, S.I.; Prusiner, S.B.; Scott, M. Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell, 1999, 96, 869-878.
133. Lawson, V.A.; Priola, S.A.; Wehrly, K.; Chesebro, B. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J. Biol. Chem., 2001, 276, 35265-35271.
134. Lawson, V.A.; Priola, S.A.; Meade-White, K.; Lawson, M.; Chesebro, B. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. J. Biol. Chem., 2004, 279, 13689-13695.
135. Maas, E.; Geissen, M.; Groschup, M.H.; Rost, R.; Onodera, T.; Schatzl, H.; Vorberg, I.M. Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins. J. Biol. Chem., 2007, 282, 18702-18710.
136. Hoshino, S.; Inoue, K.; Yokoyama, T.; Kobayashi, S.; Asakura, T.; Teramoto, A.; Itohara, S. Prions prevent brain damage after experimental brain injury: a preliminary report. Acta Neurochir. Suppl., 2003, 86, 297-299.
137. Sakurai-Yamashita, Y.; Sakaguchi, S.; Yoshikawa, D.; Okimura, N.; Masuda, Y.; Katamine, S.; Niwa, M. Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion proteinlike protein. Neuroscience, 2005, 136, 281-287.
138. Walz, R.; Amaral, O.B.; Rockenbach, I.C.: Roesler, R.: Izquierdo, I.; Cavalheiro, E.A.; Martins, V.R.; Brentani, R.R. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia, 1999, 40, 1679-1682.
139. Houston, F.; Foster, J.D.; Chong, A.; Hunter, N.; Bostock, C.J. Transmission of BSE by blood transfusion in sheep. Lancet, 2000, 356, 999-1000.
140. Inoue, Y.; Yamakawa, Y.: Sakudo, A.; Kinumi, T.; Nakamura, Y.; Matsumoto, Y.; Saeki, K.; Kamiyama, T.; Onodera, T.; Nishijima, M. Infection route-independent accumulation of splenic abnormal prion protein. Jpn. J. Infect. Dis., 2005, 58, 78-82.